F Ataúlfo González - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Transfusion|January 5, 2019

Improving safety in blood transfusion using failure mode and effect analysisAsunción Mora, Luis Ayala, Rafael Bielza, et al.

Medicina Clinica|October 5, 2007

[Fannin-Lubbock II hemoglobin [beta111(G13)Val -> Leu y beta119(GH2)Gly -> Asp]: description of 4 new cases]F Ataúlfo González, Paloma Ropero, Beatriz Arrizabalaga, et al.

Anales De Pediatria (Barcelona, Spain : 2003)|December 3, 2004

[Congenital xerocytosis]E Aleo Luján, C Gil López, F Ataúlfo González, et al.

European Journal of Haematology|December 10, 2020

One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumabAustin G Kulasekararaj, Anita Hill, Saskia Langemeijer, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Transfusion|January 5, 2019

Improving safety in blood transfusion using failure mode and effect analysisAsunción Mora, Luis Ayala, Rafael Bielza, et al.

Medicina Clinica|October 5, 2007

[Fannin-Lubbock II hemoglobin [beta111(G13)Val -> Leu y beta119(GH2)Gly -> Asp]: description of 4 new cases]F Ataúlfo González, Paloma Ropero, Beatriz Arrizabalaga, et al.

Anales De Pediatria (Barcelona, Spain : 2003)|December 3, 2004

[Congenital xerocytosis]E Aleo Luján, C Gil López, F Ataúlfo González, et al.

European Journal of Haematology|December 10, 2020

One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumabAustin G Kulasekararaj, Anita Hill, Saskia Langemeijer, et al.

Pageof 1